Macrophage infiltration and its prognostic implications in breast cancer: The relationship with VEGF expression and microvessel density

Oncology Reports

Volumn 14, Issue 2, 2005, Pages 425-431

  Tsutsui, Shinichi ^a   Yasuda, Kazuhiro ^a   Suzuki, Kosuke ^a   Tahara, Kouichirou ^a   Higashi, Hidefumi ^a   Era, Shoichi ^a  

^a NATIONAL HOSPITAL ORGANIZATION BEPPU MEDICAL CENTER   (Japan)

Author keywords

Angiogenesis; Breast cancer; Microvessel density; Tumor associated macrophages; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN A;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; BREAST TUMOR; DISEASE FREE SURVIVAL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MACROPHAGE; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PROGNOSIS; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 24744454660     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.14.2.425     Document Type: Article

References (38)

1. Folkman J: Clinical applications of research on angiogenesis. N Engl J Med 333: 1757-1763, 1995.
2. Hanahan D and Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364, 1996. (Pubitemid 26272076)
3. Tsutsui S, Kume M and Era S: Prognostic value of microvessel density in invasive ductal carcinoma of the breast. Breast Cancer 10: 312-319, 2003.
4. Mantovani A, Bottazzi B, Colotta F, Sozzani S and Ruco L: The origin and function of tumor-associated macrophages. Immunol Today 13: 265-270, 1992.
5. Sunderkotter C, Steinbrink K, Goebeler M, Bhardwaj R and Sorg C: Macrophages and angiogenesis. J Leukoc Biol 55: 410-422, 1994. (Pubitemid 24097250)
6. Bingle L, Brown NJ and Lewis CE: The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 196: 254-265, 2002. (Pubitemid 34189413)
7. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J and Harris AL: Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56: 4625-4629, 1996. (Pubitemid 26338061)
8. Lee AHS, Happerfield LC, Bobrow LG and Millis RR: Angiogenesis and inflammation in invasive carcinoma of the breast. J Clin Pathol 50: 669-673, 1997. (Pubitemid 27396070)
9. Volodko N, Reiner A, Rudas M and Jakesz R: Tumour-associated macrophages in breast cancer and their prognostic correlations. Breast 7: 99-105, 1998. (Pubitemid 28230834)
10. Jonjic N, Valkovic T, Lucin K, et al: Comparison of microvessel density with tumor associated macrophages in invasive breast carcinoma. Anticancer Res 18: 3767-3770, 1998. (Pubitemid 28564262)
11. Valkovic T, Dobrila F, Melato M, Sasso F, Rizzaardi C and Jojic N: Correlation between vascular endothelial growth factor, angiogenesis and tumor-associated macrophages in invasive ductal breast carcinoma. Virchows Arch 440: 583-588, 2002. (Pubitemid 34809688)
12. Lissbrant IF, Stattin P, Wikstrom P, Damber JE, Egevad L and Bergh A: Tumour associated macrophages in human prostate cancer: relation to clinicopathological variables and survival. Int J Oncol 17: 445-451, 2000.
13. Shimura S, Yang G, Ebara S, Wheeler TM, Frolov A and Thompson TC: Reduced infiltration of tumour-associated macrophages in human prostate cancer: association with cancer progression. Cancer Res 60: 5857-5861, 2000.
14. Orre M and Rogers PAW: Macrophages and microvessel density in tumors of the ovary. Gynecol Oncol 73: 47-50, 1999. (Pubitemid 29177598)
15. Salvesen HB and Aksleen LA: Significance of tumour-associated macrophages, vascular endothelial growth factor and thrombospodin-1 expression for tumour angiogenesis and prognosis in endometrial carcinomas. Int J Cancer 84: 539-543, 1999.
16. Fujimoto J, Sakaguchi H, Aoki I and Tamaya T: Clinical implications of expression of interleukin 8 related to angiogenesis in uterine cervical cancers. Cancer Res 60: 2632-2635, 2000. (Pubitemid 30318237)
17. Koukourakis MI, Giatromanolaki A, Kakolyris S, et al: Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival. Br J Cancer 77: 1696-1703, 1998. (Pubitemid 28230477)
18. Hanada T, Nakagawa M, Emoto A, Nomura T, Nasu N and Nomura Y: Prognostic value of tumour-associated macrophage count in human bladder cancer. Int J Urol 7: 263-269, 2000. (Pubitemid 30440592)
19. Nishie A, Ono M, Shono T, et al: Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas. Clin Cancer Res 5: 1107-1113, 1999. (Pubitemid 29233226)
20. Rossi ML, Jones NR, Candy E, et al: The mononuclear cell infiltrate compared with survival in high-grade astrocytomas. Acta Neuropathol 78: 189-193, 1999.
21. Makitie T, Summanen P, Tarkkanen A and Kivela T: Tumor-infiltrating macrophages (CD68+ cells) and prognosis in malignant uveal melanoma. Invest Ophthalmol Vis Sci 42: 1414-1421, 2001. (Pubitemid 32520728)
22. Tsutsui S, Yasuda K, Higashi H, et al: Prognostic implication of p53 protein expression in relation to nuclear pleomorphism and the MIB-1 counts in breast cancer. Breast Cancer 11: 160-168, 2004.
23. Volm M, Koomagi R and Mattern J: Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer. Int J Cancer 74: 64-68, 1997. (Pubitemid 27157857)
24. Medri L, Nanni O, Volpi A, et al: Tumor microvessel density and prognosis in node-negative breast cancer. Int J Cancer 89: 74-80, 2000. (Pubitemid 30078753)
25. Gasparini G, Weider N, Bevilacqua P, et al: Tumor microvessel density, p53 expression, tumor size and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol 12: 454-466, 1994. (Pubitemid 24079885)
26. Xiong M, Elson G, Legarda D and Leibovich SJ: Production of vascular endothelial growth factor by murine macrophages. Am J Pathol 153: 587-598, 1998.
27. Fukumura D, Xavier R, Sugiura T, et al: Tumor induction of VEGF promoter activity in stromal cells. Cell 94: 715-725, 1998. (Pubitemid 28436004)
28. Clauss M, Gerlach M, Gerlach H, et al: Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 172: 1535-1545, 1990.
29. Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A and Marme D: Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87: 3336-3343, 1996. (Pubitemid 26115364)
30. Lewis JS, Landers RJ, Underwood JCE, Harris AL and Lewis CE: Expression of vascular endothelial growth factor by macrophage is up-regulated in poorly vascularized areas of breast carcinomas. J Pathol 192: 150-158, 2000.
31. Leek RD, Hunt NC, Landers RJ, Lewis CE, Royds JA and Harris AL: Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer. J Pathol 190: 430-436, 2000. (Pubitemid 30163582)
32. Koch AE, Polverini PJ, Kunkel SL, et al: Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258: 1798-1801, 1992. (Pubitemid 23087348)
33. Pusztai L, Clover LM, Cooper K, Starkey PM, Lewis CE and McGee JOD: Expression of tumour necrosis factor alpha and its receptors in carcinoma of the breast. Br J Cancer 70: 289-292, 1994. (Pubitemid 24247151)
34. Etoh T, Shibuta K, Barnard GF, Kitano S and Mori M: Angiogenin expression in human colorectal cancer: the role of focal macrophage infiltration. Clin Cancer Res 6: 3545-3551, 2000.
35. Talks KL, Turley H, Gatter KC, et al: The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers and tumor-associated macrophages. Am J Pathol 157: 411-421, 2000. (Pubitemid 30626905)
36. Harmey JH, Dimitriadis E, Kay E, Redmond HP and Bouchier-Hayes D: Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor β-1. Ann Surg Oncol 5: 271-278, 1997.
37. Lewis JS, Lee JA, Underwood JCE, Harris AL and Lewis CE: Macrophage response to hypoxia: relevance to disease mechanisms. J Leukoc Biol 66: 889-900, 1999. (Pubitemid 30010512)
38. Wu S, Boyer CM, Whitaker RS, et al: Tumor necrosis factor α as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor α expression. Cancer Res 53: 1939-1944, 1993. (Pubitemid 23127128)